Your partner for Dx compliance in translational research

whitepaper

IVDR: Are your Companion Diagnostic Partners Ready?

by ARC Insights
Scientist and microscope

Scientist and microscope

In this whitepaper, we will provide an overview of the transitional activities required under the IVDR and their status, as well as examine the most significant new requirements and assess their impact on CDx (companion diagnostic) manufacturers and their pharmaceutical.

IVDR: Are your Companion Diagnostic Partners Ready?

In this whitepaper, we will provide an overview of the transitional activities required under the IVDR and their status, as well as examine the most significant new requirements and assess their impact on CDx (companion diagnostic) manufacturers and their pharmaceutical collaborators.

ARC Regulatory whitepaper cover

FREE DOWNLOAD

ARC Regulatory logo
Article written by ARC Insights
ARC Insights offers a mix of industry specific content with the aim to keep its readers informed, educated, and up to date with the latest developments, trends, and expert knowledge in the FiH translational medicine space.
CTA

Get in touch with our expert team today